Clinical Trials Directory

Trials / Unknown

UnknownNCT04437056

Nerve Transfers in Post-stroke Spasticity

Outcome Measurements After Cognitive Nerve Transfers to Spastic Muscles in Stroke Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Stroke is nowadays a leading cause of disability with devastating sequelae. Upper limb spasticity is one of them. Nevertheless, not all the muscles are equally affected, as some may turn spastic or paretic and other remain intact. This unique pathophysiological mosaic dictates a precise therapeutic plan. Existing spasticity treatment has significant drawbacks due to its unspecific targeting and short duration. A causal, life-lasting treatment, precisely adapted to every single patient's needs and to disease pattern, is currently missing. Hyperselective muscle denervation and subsequent cognitive reinnervation with appropriate unaffected donor nerves may break the pathological spastic circuit and provide volitional muscle control. With this pioneering study we will perform cognitive nerve transfers to spastic muscles and will prospectively investigate their effects on clinical, electrophysiological, molecular-biological and histological level. Accurate donor nerve selection will be for the first time quantified through motor unit number estimation with high-density needle electromyography. This revolutionary concept can open the window to a new era of therapeutic possibilities for stroke victims.

Conditions

Interventions

TypeNameDescription
PROCEDURECognitive nerve transfers to spastic upper extremity muscles in stroke patientsBased on the fact that upper motor neuron syndrome after stroke is presented with variable clinical features, usually without affecting in the same way the entire upper extremity, we aim to investigate the efficacy of nerve transfers to spastic muscles after stroke using as donor nerves that innervate unaffected ipsilateral volitionally controlled muscles.

Timeline

Start date
2020-09-01
Primary completion
2023-12-31
Completion
2025-12-31
First posted
2020-06-18
Last updated
2022-04-12

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04437056. Inclusion in this directory is not an endorsement.